SCHEMBL19474279

SCHEMBL19474279

CCN(CC(c1ccccc1)c1ccccc1)C(=O)C(CCCNC(=N)N)NCCNC(=O)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 1/20 0.43
▸ OPRM1 P35372 2/20 0.42
▸ TMEM97 Q5BJF2 2/20 0.42
▸ SIGMAR1 Q99720 2/20 0.42
▸ DRD3 P35462 5/20 0.41
▸ DRD2 P14416 4/20 0.41
▸ HDAC3 O15379 7/20 0.40
▸ HDAC1 Q13547 7/20 0.40
▸ HDAC2 Q92769 6/20 0.40
▸ HDAC4 P56524 5/20 0.40
▸ HDAC7 Q8WUI4 5/20 0.40
▸ HDAC10 Q969S8 5/20 0.40
▸ HDAC11 Q96DB2 5/20 0.40
▸ HDAC8 Q9BY41 5/20 0.40
▸ HDAC6 Q9UBN7 5/20 0.40
▸ HDAC9 Q9UKV0 5/20 0.40
▸ HDAC5 Q9UQL6 5/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ TPSAB1 Q15661 1/20 0.37
▸ ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19474263 1.00 CCKBR (0.43) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13188839 0.85 TMEM97 (0.42) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13190968 0.83 OPRM1 (0.46) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13689530 0.82 OPRM1 (0.42) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13691768 0.81 OPRM1 (0.45) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13188826 0.80 OPRM1 (0.49) OPRM1TMEM97SIGMAR1DRD3DRD2
SCHEMBL15372793 0.80 MC4R (0.38) —
SCHEMBL13691772 0.79 OPRM1 (0.46) CCKBROPRM1TMEM97SIGMAR1DRD3
SCHEMBL13689518 0.79 OPRM1 (0.47) CCKBROPRM1TMEM97SIGMAR1HDAC3
SCHEMBL13691769 0.78 OPRM1 (0.46) CCKBROPRM1TMEM97SIGMAR1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257297-B1 COMPOUNDS FOR USE IN THE TREATMENT OF ACNE, SEBORRHOEA AND SEBHORROEIC DERMATITIS, OR FOR REDUCING SEBUM SECRETION MIMETICA PTY LTD (AU) 2017-10-18 — — EP disclosed
Send feedback